Projected Income Statement: Orange

Forecast Balance Sheet: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 24,269 25,298 27,002 22,482 22,526 41,535 40,173 38,212
Change - 4.24% 6.74% -16.74% 0.2% 84.39% -3.28% -4.88%
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 18/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 7,660 7,371 6,815 6,425 6,208 7,477 7,640 7,567
Change - -3.77% -7.54% -5.72% -3.38% 20.44% 2.18% -0.96%
Free Cash Flow (FCF) 1 3,576 3,864 5,239 3,770 4,572 1,251 4,898 5,334
Change - 8.05% 35.58% -28.04% 21.27% -72.65% 291.7% 8.89%
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 18/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 29.55% 29.82% 29.54% 30.08% 30.87% 32.08% 32.61% 33.47%
EBIT Margin (%) 18.74% 13.67% 12.71% 13.63% 11.31% 13.78% 14.07% 14.45%
EBT Margin (%) 4.09% 8.93% 8.53% 10.57% 5.47% 10.47% 10.67% 11.38%
Net margin (%) 0.55% 4.94% 5.53% 5.84% 1.33% 6% 6.17% 6.78%
FCF margin (%) 8.41% 8.89% 11.87% 9.36% 11.32% 2.8% 9.99% 10.69%
FCF / Net Income (%) 1,534.76% 180.06% 214.71% 160.43% 849.81% 46.72% 161.78% 157.58%

Profitability

        
ROA 0.22% 1.97% 2.22% 2.2% 0.51% 2.34% 2.52% 2.78%
ROE 6.1% 6.69% 7.67% 7.39% 1.75% 8.84% 8.93% 10.01%

Financial Health

        
Leverage (Debt/EBITDA) 1.93x 1.95x 2.07x 1.86x 1.81x 2.9x 2.51x 2.29x
Debt / Free cash flow 6.79x 6.55x 5.15x 5.96x 4.93x 33.21x 8.2x 7.16x

Capital Intensity

        
CAPEX / Current Assets (%) 18.01% 16.96% 15.45% 15.96% 15.37% 16.77% 15.57% 15.16%
CAPEX / EBITDA (%) 60.96% 56.86% 52.28% 53.06% 49.78% 52.27% 47.76% 45.28%
CAPEX / FCF (%) 214.21% 190.76% 130.08% 170.42% 135.78% 597.9% 155.96% 141.86%

Items per share

        
Cash flow per share 1 4.228 4.182 4.531 3.833 4.052 3.87 4.257 4.342
Change - -1.09% 8.35% -15.4% 5.72% -4.5% 10% 2%
Dividend per Share 1 0.7 0.7 0.7 0.72 0.75 0.7872 0.8196 0.8513
Change - 0% 0% 2.86% 4.17% 4.96% 4.11% 3.87%
Book Value Per Share 1 12.16 11.96 11.97 11.95 11.19 11.75 12.44 13.41
Change - -1.66% 0.1% -0.14% -6.39% 5.06% 5.86% 7.77%
EPS 1 - 0.73 0.85 0.82 0.14 1.019 1.145 1.247
Change - - 16.44% -3.53% -82.93% 627.85% 12.41% 8.88%
Nbr of stocks (in thousands) 26,31,971 26,57,122 26,59,182 26,58,153 26,58,600 26,59,283 26,59,283 26,59,283
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 18/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 17.1x 15.2x
PBR 1.48x 1.4x
EV / Sales 1.97x 1.76x
Yield 4.51% 4.7%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
17.44EUR
Average target price
18.44EUR
Spread / Average Target
+5.74%

Quarterly revenue - Rate of surprise